Christopher A. Teleha

1.3k total citations
32 papers, 668 citations indexed

About

Christopher A. Teleha is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Christopher A. Teleha has authored 32 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 17 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Christopher A. Teleha's work include Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Christopher A. Teleha is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Christopher A. Teleha collaborates with scholars based in United States, Germany and Belgium. Christopher A. Teleha's co-authors include Jung‐Hui Sun, David A. Nugiel, James D. Rodgers, Leo A. Paquette, Robert M. Knabb, Richard Alexander, Charles G. Clark, Renhua Li, Pancras C. Wong and Ruth R. Wexler and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Christopher A. Teleha

32 papers receiving 633 citations

Peers

Countries citing papers authored by Christopher A. Teleha

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Teleha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Teleha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Teleha more than expected).

Fields of papers citing papers by Christopher A. Teleha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Teleha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Teleha. The network helps show where Christopher A. Teleha may publish in the future.

Co-authorship network of co-authors of Christopher A. Teleha

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Teleha. A scholar is included among the top collaborators of Christopher A. Teleha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Teleha. Christopher A. Teleha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC) 2021 ·Journal of Medicinal Chemistry ·Zhuming Zhang, Peter J. Connolly, Hyun Kyoon Lim, Vineet Pande, Lieven Meerpoel, Christopher A. Teleha, Jonathan R. Branch, (unknown), Ian Hickson, Tammy L. Bush, Leopoldo Luistro, Kathryn Packman, James R. Bischoff, Salam A. Ibrahim, (unknown), Yolanda Chong, Marco M. Gottardis, Gilles Bignan	22
2	Practical Synthesis of Ethyl 3-Fluoro-1-pyrrole-2-carboxylate: A Key Fragment of a Potent Drug Candidate against Hepatitis B Virus 2019 ·Organic Process Research & Development ·(unknown), (unknown), (unknown), Yang Cheng, Christopher A. Teleha, Pierre Raboisson, Jean‐François Bonfanti, Jérôme Fortin, André B. Charette, Xavier Pannecoucke, Thomas Poisson, Philippe Jubault	12
3	6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB₁) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity 2018 ·Journal of Medicinal Chemistry ·(unknown), Michael N. Greco, Mark J. Macielag, Christopher A. Teleha, Renée L. DesJarlais, Yuting Tang, (unknown), Cuifen Hou, Cailin Chen, Shuyuan Zhao, Jack A. Kauffman, Raul C. Camacho, Jenson Qi, William V. Murray, Keith T. Demarest, James Leonard	12
4	Synthesis of Mavatrep: A Potent Antagonist of Transient Receptor Potential Vanilloid-1 2015 ·Organic Process Research & Development ·Kenneth M. Wells, Steven J. Mehrman, Ahmed F. Abdel‐Magid, Caterina Ferraro, (unknown), (unknown), Christopher A. Teleha, (unknown), Xun Li, Ronald K. Russell, (unknown), Craig J. Diamond, (unknown), (unknown), Fuh‐Rong Tsay, (unknown), (unknown), Derek A. Beauchamp	2
5	The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2 2014 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Winters, Christopher A. Teleha, Fu‐An Kang, David F. McComsey, John O’Neill, Cuifen Hou, Thomas Kirchner, Ping Wang, Dana L. Johnson, Zhihua Sui	5
6	Synthesis of substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles by intramolecular nitrilimine cycloaddition 2014 ·Tetrahedron Letters ·Michael P. Winters, Christopher A. Teleha, Zhihua Sui	14
7	Lab-Scale Preparation of a Novel Cyclopenta[b]furan Chemokine Receptor Antagonist 2014 ·Organic Process Research & Development ·Christopher A. Teleha, (unknown), Yongzheng Zhang, Michael Reuman, (unknown), (unknown), (unknown), Gregory C. Leo, Michael P. Winters, Fu‐An Kang, (unknown), Derek A. Beauchamp, James C. Lanter, Ronald K. Russell, Zhihua Sui, (unknown)	7
8	Lab-Scale Preparation of a Novel Carbocyclic Chemokine Receptor Antagonist 2014 ·Organic Process Research & Development ·Christopher A. Teleha, (unknown), Yong‐Zheng Zhang, Michael Reuman, (unknown), (unknown), (unknown), Gregory C. Leo, Fu‐An Kang, Chaozhong Cai, (unknown), Derek A. Beauchamp, Mark J. Wall, Ronald K. Russell, Zhihua Sui, (unknown)	6
9	Preparation of α-Hydroxy-β-Fmoc Amino Acids from N-Boc Amino Acids 2011 ·Synthesis ·Christopher A. Teleha, Erik P. Johnson, (unknown), Andrew P. Combs	3
10	Synthesis of an αvβ3 integrin antagonist intermediate via asymmetric hydrogenation of an α,β-unsaturated ester with BoPhoz-iridium and BoPhoz-rhodium catalysts 2008 ·Tetrahedron Asymmetry ·Antonio Zanotti‐Gerosa, William A. Kinney, Gabriela A. Grasa, Jonathan Medlock, Andreas Seger, Shyamali Ghosh, Christopher A. Teleha, Bruce E. Maryanoff	12
11	Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor 2004 ·Journal of Medicinal Chemistry ·Mimi L. Quan, Patrick Y. S. Lam, Qi Han, Donald Pinto, Ming He, Renhua Li, Christopher D. Ellis, Charles G. Clark, Christopher A. Teleha, Jung‐Hui Sun, Richard Alexander, Steve Bai, Joseph M. Luettgen, Robert M. Knabb, Pancras C. Wong, Ruth R. Wexler	147
12	Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands 2003 ·Bioorganic & Medicinal Chemistry Letters ·Argyrios G. Arvanitis, (unknown), (unknown), Richard G. Wilde, Gary A. Cain, (unknown), (unknown), Christopher A. Teleha, Lawrence W. Fitzgerald, John Mcelroy, Robert Zaczek, Paul Hartig, Scott Grossman, Stephen P. Arnerić, Paul J. Gilligan, Richard E. Olson, David W. Robertson	11
13	Isolation and synthesis of 2-chloro-10-α-hydroxynaltrexone, a new naltrexone degradant 2003 ·Tetrahedron Letters ·(unknown), Gregory A. Nemeth, Robert Boucher, Robert L. Carney, Michael Haas, (unknown), Christopher A. Teleha	6
14	Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor α 2002 ·The Journal of Steroid Biochemistry and Molecular Biology ·Ranjan Mukherjee, Shaoxian Sun, Linda D. Santomenna, Bowman Miao, Harry L. Walton, (unknown), (unknown), Ji-Hu Zhang, (unknown), (unknown), Kathleen Murphy, (unknown), Menghang Xia, Christopher A. Teleha, (unknown), Bernard Selling, Richard Wynn, Timothy C. Burn, Peter R. Young	36
15	A CONVENIENT SYNTHESIS OF N-Boc-4-FORMYLPIPERINE 2000 ·Organic Preparations and Procedures International ·Gary A. Cain, Christopher A. Teleha	2
16	2-Fluoro-4-pyridinylmethyl Analogues of Linopirdine as Orally Active Acetylcholine Release-Enhancing Agents with Good Efficacy and Duration of Action 1998 ·Journal of Medicinal Chemistry ·Richard A. Earl, Robert Zaczek, Christopher A. Teleha, (unknown), Carla Maciag, (unknown), (unknown), S. William Tam, (unknown), Shiew‐Mei Huang, Robert J. Chorvat	25
17	Synthesis and unexpected reactions of 2‐Hydroxy‐3‐pyridinylacetic hydrazides. Formation of 2H‐Pyrrolo[2,3‐b]pyridin‐2‐ones 1998 ·Journal of Heterocyclic Chemistry ·Christopher A. Teleha, Roger A. Greenberg, Robert J. Chorvat	4
18	Effects of linopirdine, HP 749, and glycyl‐prolyl‐glutamate on transmitter release and uptake 1993 ·Drug Development Research ·Robert Zaczek, (unknown), (unknown), Gary A. Cain, Christopher A. Teleha, S. William Tam	15
19	Boat/chair topographic stereoselection during anionic oxy-Cope rearrangement of 1-alkenyl-2-cyclopentenyl-endo-norbornan-2-ols 1990 ·Journal of the American Chemical Society ·Leo A. Paquette, Christopher A. Teleha, Richard T. Taylor, George D. Maynard, Robin D. Rogers, Judith C. Gallucci, James P. Springer	22
20	Intramolecular SN' cleavage of allylic ethers by enolate anions 1989 ·Journal of the American Chemical Society ·Leo A. Paquette, Jeff D. Reagan, Stuart L. Schreiber, Christopher A. Teleha	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact